Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016090513> ?p ?o ?g. }
- W2016090513 endingPage "1534" @default.
- W2016090513 startingPage "1523" @default.
- W2016090513 abstract "RNA interference (RNAi) mediates sequence-specific gene silencing, which can be harnessed to silencing disease-causing genes for therapy. Particularly suitable diseases are those caused by dominant, gain-of-function type of gene mutations. In these diseases, the mutant gene generates a mutant protein or RNA product, which possesses toxic properties that harm cells. By silencing the mutant gene, the toxicity can be lessened because the amount of the toxic product is lowered in cells. In this report, we tested RNAi therapy in a mouse model for amyotrophic lateral sclerosis (ALS), which causes motor neuron degeneration, paralysis, and death. We used a transgenic model that overexpresses mutant Cu, Zn superoxide dismutase (SOD1G93A), which causes ALS by a gained toxic property. We delivered RNAi using recombinant adenovirus (RAd) and adeno-associated virus serotype 2 (AAV2). We compared the efficiency of RNAi delivery between injecting the viral vectors into muscle and into nerve, and found that nerve injetion is more efficient in delivering RNAi to motor neurons. Based on this data, we conducted therapeutic trials in the mouse model and found that nerve injection of RAd, but not AAV2, at the disease onset had a modest therapeutic efficacy. These results highlight the potential and the challenges in delivering RNAi therapy by gene therapy." @default.
- W2016090513 created "2016-06-24" @default.
- W2016090513 creator A5013725855 @default.
- W2016090513 creator A5026394330 @default.
- W2016090513 creator A5036236379 @default.
- W2016090513 creator A5040825774 @default.
- W2016090513 creator A5046015862 @default.
- W2016090513 creator A5051823639 @default.
- W2016090513 creator A5056027964 @default.
- W2016090513 date "2009-07-01" @default.
- W2016090513 modified "2023-10-17" @default.
- W2016090513 title "Nerve Injection of Viral Vectors Efficiently Transfers Transgenes into Motor Neurons and Delivers RNAi Therapy Against ALS" @default.
- W2016090513 cites W1488480791 @default.
- W2016090513 cites W1519383882 @default.
- W2016090513 cites W1611419331 @default.
- W2016090513 cites W1619082318 @default.
- W2016090513 cites W1626177217 @default.
- W2016090513 cites W1972637758 @default.
- W2016090513 cites W1978701238 @default.
- W2016090513 cites W1979837223 @default.
- W2016090513 cites W1982857430 @default.
- W2016090513 cites W1997249015 @default.
- W2016090513 cites W2000695783 @default.
- W2016090513 cites W2000725549 @default.
- W2016090513 cites W2002104055 @default.
- W2016090513 cites W2003618511 @default.
- W2016090513 cites W2010791234 @default.
- W2016090513 cites W2013135033 @default.
- W2016090513 cites W2015741336 @default.
- W2016090513 cites W2018110972 @default.
- W2016090513 cites W2022367303 @default.
- W2016090513 cites W2027541220 @default.
- W2016090513 cites W2029911967 @default.
- W2016090513 cites W2031964319 @default.
- W2016090513 cites W2032107666 @default.
- W2016090513 cites W2033158384 @default.
- W2016090513 cites W2034849392 @default.
- W2016090513 cites W2035943396 @default.
- W2016090513 cites W2037141750 @default.
- W2016090513 cites W2038354221 @default.
- W2016090513 cites W2042739691 @default.
- W2016090513 cites W2043641895 @default.
- W2016090513 cites W2064640860 @default.
- W2016090513 cites W2064668202 @default.
- W2016090513 cites W2065958196 @default.
- W2016090513 cites W2068422066 @default.
- W2016090513 cites W2072978915 @default.
- W2016090513 cites W2096628715 @default.
- W2016090513 cites W2099071260 @default.
- W2016090513 cites W2101555677 @default.
- W2016090513 cites W2104979554 @default.
- W2016090513 cites W2107768418 @default.
- W2016090513 cites W2110284480 @default.
- W2016090513 cites W2117648777 @default.
- W2016090513 cites W2121726690 @default.
- W2016090513 cites W2124084307 @default.
- W2016090513 cites W2125606478 @default.
- W2016090513 cites W2127861463 @default.
- W2016090513 cites W2128674168 @default.
- W2016090513 cites W2128701198 @default.
- W2016090513 cites W2128815118 @default.
- W2016090513 cites W2132377220 @default.
- W2016090513 cites W2136447541 @default.
- W2016090513 cites W2141573080 @default.
- W2016090513 cites W2147835141 @default.
- W2016090513 cites W2153478121 @default.
- W2016090513 cites W2156806006 @default.
- W2016090513 cites W2160678872 @default.
- W2016090513 cites W2161239543 @default.
- W2016090513 cites W2169402836 @default.
- W2016090513 cites W2174590326 @default.
- W2016090513 cites W2174973932 @default.
- W2016090513 cites W346842856 @default.
- W2016090513 doi "https://doi.org/10.1089/ars.2009.2618" @default.
- W2016090513 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2842583" @default.
- W2016090513 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19344276" @default.
- W2016090513 hasPublicationYear "2009" @default.
- W2016090513 type Work @default.
- W2016090513 sameAs 2016090513 @default.
- W2016090513 citedByCount "22" @default.
- W2016090513 countsByYear W20160905132012 @default.
- W2016090513 countsByYear W20160905132013 @default.
- W2016090513 countsByYear W20160905132014 @default.
- W2016090513 countsByYear W20160905132016 @default.
- W2016090513 countsByYear W20160905132017 @default.
- W2016090513 countsByYear W20160905132019 @default.
- W2016090513 countsByYear W20160905132020 @default.
- W2016090513 countsByYear W20160905132021 @default.
- W2016090513 countsByYear W20160905132023 @default.
- W2016090513 crossrefType "journal-article" @default.
- W2016090513 hasAuthorship W2016090513A5013725855 @default.
- W2016090513 hasAuthorship W2016090513A5026394330 @default.
- W2016090513 hasAuthorship W2016090513A5036236379 @default.
- W2016090513 hasAuthorship W2016090513A5040825774 @default.
- W2016090513 hasAuthorship W2016090513A5046015862 @default.
- W2016090513 hasAuthorship W2016090513A5051823639 @default.
- W2016090513 hasAuthorship W2016090513A5056027964 @default.
- W2016090513 hasBestOaLocation W20160905132 @default.